miR-520h Stimulates Drug Resistance to Paclitaxel by Targeting the OTUD3-PTEN Axis in Breast Cancer

Table 1

Relationship between miR-520h, OTUD3, and PTEN expression and the clinicopathologic characteristics in breast cancer.

Clinicopathologic characteristics	miR-520h			OTUD3			PTEN
	High	Low		High	Low		High	Low
Age			0.079			0.308			0.745
≤50	49	22		22	49		26	45
>50	47	38		33	52		29	56
Tumor size			0.041			0.007			0.001
≤2 cm	48	40		39	49		41	47
>2 cm	48	20		16	52		14	54
Histological grade			0.027			0.009			0.300
I	32	28		30	30		25	35
II	42	13		15	39		15	39
III	23	19		10	32		15	27
Lymph nodes			0.030			0.025			0.594
Negative	50	42		39	16		34	58
Positive	46	18		53	48		21	43
ER status			0.521			0.503			0.545
Negative	20	10		9	21		12	18
Positive	76	50		46	80		43	83
PR status			0.233			0.513			0.409
Negative	25	21		18	28		20	26
Positive	71	39		37	73		33	75
HER2 status			0.074			0.371			0.066
Negative	78	55		45	88		43	90
Positive	18	5		10	13		12	11